Boundless Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.61

-0.05 (-1.88%)

As of Sep 28, 10:36 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +367.0% upside

Low Target $8.12

Average Target $12.19

High Target $14.26

Current Price $2.61

Current
$2.61

Target
$12.19

$8.12 $12.19 avg $14.26

Scenario Analysis

Bear Case

$8.12

211.1%

Low target

Base Case

$12.19

+367.0%

Avg target

Bull Case

$14.26

+446.4%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$3.16

-17.5% from high

52-Week Low

$0.96

+171.5% from low

Target vs 52W High

$12.19

+285.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%